Santhera Pharmaceuticals Holding AG (LON: 0QN1)

Santhera Pharmaceuticals Holding AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 23, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	186	84	68	45	45	98
Market Cap Growth	-1.70%	24.57%	49.48%	1.30%	-54.55%	72.36%
Enterprise Value	195	121	93	74	80	138
Last Close Price	14.67	9.15	12.58	10.29	22.72	89.66
PE Ratio	3.36	1.65	-	-	-	-
PS Ratio	0.83	0.87	10.08	-35.00	3.59	1.67
PB Ratio	1.96	1.51	-1.72	42.04	-8.49	5.93
P/FCF Ratio	1.99	1.91	-	-	-	50.46
P/OCF Ratio	1.99	1.91	-	-	-	48.56
EV/Sales Ratio	1.92	1.26	13.82	-	6.41	2.35
EV/EBITDA Ratio	3.78	2.42	-	-	-	-
EV/EBIT Ratio	4.06	2.54	-	-	-	-
EV/FCF Ratio	4.69	2.76	-	-	-	71.03
Debt / Equity Ratio	0.55	0.36	-1.02	32.36	-11.20	2.82
Debt / EBITDA Ratio	0.46	0.40	-	-	-	-
Debt / FCF Ratio	0.56	0.46	-	-	-	24.03
Asset Turnover	1.33	1.19	0.10	-	0.15	0.67
Inventory Turnover	-	3.37	13.40	8.29	2.84	0.68
Quick Ratio	0.51	0.73	0.05	0.71	0.58	1.68
Current Ratio	0.63	0.78	0.06	0.75	0.61	2.06
Return on Equity (ROE)	2374.13%	673.95%	-	-	-908.60%	-77.32%
Return on Assets (ROA)	39.20%	36.89%	-36.95%	-39.55%	-32.56%	-5.79%
Return on Capital (ROIC)	91.78%	77.76%	-126.97%	-65.17%	-45.43%	-7.98%
Earnings Yield	29.74%	60.65%	-94.37%	-99.46%	-125.46%	-15.06%
FCF Yield	22.33%	52.24%	-39.69%	-66.93%	-80.73%	1.98%
Buyback Yield / Dilution	-24.61%	-79.29%	-78.31%	-156.61%	-21.15%	-59.49%
Total Shareholder Return	-24.61%	-79.29%	-78.31%	-156.61%	-21.15%	-59.49%

Source: S&P Capital IQ. Standard template. Financial Sources.